The pharmaceutical industry is built on precision, purity, and the reliable availability of high-quality raw materials. For drug development and manufacturing, chemical intermediates are the foundational building blocks that enable complex synthesis pathways. 4-Ethenylphenol Acetate (CAS 2628-16-2), also known as 4-Acetoxystyrene, is one such intermediate that holds significant value in pharmaceutical synthesis.

Understanding 4-Ethenylphenol Acetate in Pharmaceuticals

4-Ethenylphenol Acetate is an organic compound characterized by its C10H10O2 molecular formula and its typical presentation as a clear, colorless to yellowish liquid with a melting point around 7-8°C. Its chemical structure makes it a versatile reagent in organic chemistry. In the pharmaceutical context, its primary value lies in its ability to participate in various synthetic reactions, serving as a key component in the creation of more complex molecules, including potential active pharmaceutical ingredients (APIs).

The specific synthetic routes and final drug products that utilize 4-Ethenylphenol Acetate are diverse and often proprietary. However, its functional groups allow for reactions such as polymerization, esterification, and various coupling reactions, all of which are common in pharmaceutical R&D and manufacturing.

The Importance of Purity and Sourcing

For pharmaceutical applications, the purity of chemical raw materials is non-negotiable. Impurities, even in trace amounts, can lead to:

• Unwanted Side Reactions: Affecting yield and purity of the desired product.
• Compromised Efficacy: Reducing the therapeutic effect of the final drug.
• Safety Concerns: Introducing toxic by-products that can harm patients.

Therefore, when purchasing 4-Ethenylphenol Acetate for pharmaceutical synthesis, it is critical to source it from manufacturers who adhere to stringent quality standards. Suppliers should be able to provide:

• High Purity (e.g., 99.0% min): Verified by a Certificate of Analysis (CoA).
• Regulatory Compliance: Certifications such as GMP (Good Manufacturing Practice) or adherence to USP/BP/EP standards are highly desirable, especially for later-stage development and commercial manufacturing.
• Batch Consistency: Ensuring that each delivery meets the same quality specifications.
• Traceability: Detailed records of the manufacturing process and raw material sourcing.

Procurement Strategies for Pharmaceutical Buyers

Pharmaceutical companies looking to buy 4-Ethenylphenol Acetate should adopt a strategic approach:

• Identify Reputable Manufacturers: Focus on suppliers with a proven track record in the fine chemical or pharmaceutical intermediate space. Manufacturers based in China are often competitive on price and have large production capacities.
• Request Samples: Before committing to large quantities, always request samples for internal testing and validation.
• Inquire Thoroughly: Clearly communicate your purity requirements, intended application, and any regulatory needs when sending out RFQs (Requests for Quotation).
• Evaluate Suppliers Holistically: Consider not only price but also quality control, technical support, delivery reliability, and customer service.

By partnering with a trustworthy supplier like NINGBO INNO PHARMCHEM CO.,LTD., pharmaceutical companies can secure a reliable source of high-quality 4-Ethenylphenol Acetate, ensuring the integrity and success of their drug development and manufacturing processes. The ability to buy this intermediate at a competitive price, without sacrificing quality, is fundamental to efficient pharmaceutical production.